Postoperative Adjuvant Treatment: Clinical Trials

3 trials for Postoperative Adjuvant Treatment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1
Phase 41Recruiting 1

Follow Postoperative Adjuvant Treatment: new trials by email Literature Review of Postoperative Adjuvant Treatment trials Research Report on Postoperative Adjuvant Treatment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
Bemcentinib, Nimotuzumab, radiotherapy - Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer
Phase 3RecruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University3702026-03-042026-04-17
Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
Intravenous Lidocaine infusion + Standard Anesthesia, Intravenous Dexmedetomidine infusion + Standard Anesthesia, Lidocaine + Dexmedetomidine Combination (LIDEX) + Standard Anesthesia - Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain
Phase 4RecruitingInstituto Mexicano del Seguro Social1042025-10-062025-11-28
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Liposomal doxorubicin containing regimen - Breast Cancer, Liposomal Doxorubicin
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1502022-05-012023-02-16

Narrower conditions

Agnosia (1)  ·  Breast Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Pain, Postoperative (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)  ·  Postoperative Complications (1)

Interventions

Dexmedetomidine (1)  ·  Fluocinonide (1)  ·  Lidocaine (1)  ·  Radiotherapy (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  bemcentinib (1)  ·  nimotuzumab (1)

Sponsors

Instituto Mexicano del Seguro Social (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)

Countries

China (2)  ·  Mexico (1)

Top investigators

Arnulfo Calixto Flores, Prof MD, PhD (1)

Results publications

PMID 11737181, PMID 18499604, PMID 19020142, PMID 19573663, PMID 20740215, PMID 24036842, PMID 25785316, PMID 25929655, PMID 26889627, PMID 26903197, PMID 30117019, PMID 31687018, PMID 31958741, PMID 32240402, PMID 32533519, PMID 32778146, PMID 33407156, PMID 33623424, PMID 34704710, PMID 35090535, PMID 35422388, PMID 36463344, PMID 37297968, PMID 37542100, PMID 37554513, PMID 38085848, PMID 38792558, PMID 38827237, PMID 39663167, PMID 7397378